Table:
begin	end	state
1	11	cytoplasmic
12	28	transmembrane
29	43	non-cytoplasmic
44	65	transmembrane
66	84	cytoplasmic
85	103	transmembrane
104	114	non-cytoplasmic
115	140	transmembrane
141	148	cytoplasmic
149	171	transmembrane
172	183	non-cytoplasmic
184	204	transmembrane
205	249	cytoplasmic
250	271	transmembrane
272	282	non-cytoplasmic
283	304	transmembrane
305	315	cytoplasmic
316	334	transmembrane
335	340	non-cytoplasmic
341	361	transmembrane
362	368	cytoplasmic
369	391	transmembrane
392	401	non-cytoplasmic
402	424	transmembrane
425	450	cytoplasmic

Input:
>H281DRAFT_00981 FitnessBrowser__Burk376:H281DRAFT_00981
MELEARTMKRVTVRLVPFLIVCYFIAYLDRVNVGFAALQMNKALGLSASAFGFGAGIFFI
AYFFFEVPSNLLLEKFGARRWIARIMFTWGLLAGAMAYIPHIAQYTGLSAAHVFYGLRIL
LGVAEAGFFPGVIFLLTLWFPAAYRGRVVGYFMAAIPLSTVIGGPISGALLSMDGFAGLA
GWQWVYLIEALPALILAFAVWFYLTDKPADATWLAADERDWLVARQKQEREHREAVHAFS
VKEALLNRRVLAIALIYFGANATNYGLSFFLPQIVKAFGLTNLQTGFVTSLPYIVGVISM
VYWGRHSDRKLERKRHVAIALTVAALGIAASAGLDNPVQKMIALSIAGFGIFGCLPVIWT
LPAAFLSGAAAAGGIAAINSLGNLAGFFGPYAMGWIKDSTGGFGAGLLCLAGAGLVGAAA
ALLLHHDPALEASAGTARRDASAGPPVAEY

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server